loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Repirinast, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Repirinast

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    REF. STANDARDS & IMPURITIES

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: 73080-51-0, Romet, My-5116, Isopentyl 7,8-dimethyl-4,5-dioxo-5,6-dihydro-4h-pyrano[3,2-c]quinoline-2-carboxylate, 3-methylbutyl 7,8-dimethyl-4,5-dioxo-6h-pyrano[3,2-c]quinoline-2-carboxylate, 4k8ka8b61g
    Molecular Formula
    C20H21NO5
    Molecular Weight
    355.4  g/mol
    InChI Key
    NFQIAEMCQGTTIR-UHFFFAOYSA-N
    FDA UNII
    4K8KA8B61G
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    3-methylbutyl 7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylate
    2.1.2 InChI
    InChI=1S/C20H21NO5/c1-10(2)7-8-25-20(24)15-9-14(22)16-18(26-15)13-6-5-11(3)12(4)17(13)21-19(16)23/h5-6,9-10H,7-8H2,1-4H3,(H,21,23)
    2.1.3 InChI Key
    NFQIAEMCQGTTIR-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=C(C2=C(C=C1)C3=C(C(=O)C=C(O3)C(=O)OCCC(C)C)C(=O)N2)C
    2.2 Other Identifiers
    2.2.1 UNII
    4K8KA8B61G
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline -2-carboxylate

    2. My 5116

    3. My-5116

    2.3.2 Depositor-Supplied Synonyms

    1. 73080-51-0

    2. Romet

    3. My-5116

    4. Isopentyl 7,8-dimethyl-4,5-dioxo-5,6-dihydro-4h-pyrano[3,2-c]quinoline-2-carboxylate

    5. 3-methylbutyl 7,8-dimethyl-4,5-dioxo-6h-pyrano[3,2-c]quinoline-2-carboxylate

    6. 4k8ka8b61g

    7. Repirinastum

    8. Repirinastum [inn-latin]

    9. 3-methylbutyl 5-hydroxy-7,8-dimethyl-4-oxopyrano[3,2-c]quinoline-2-carboxylate

    10. Repirinast [usan:inn:jan]

    11. Brn 4267921

    12. Unii-4k8ka8b61g

    13. Repirinast-[d4]

    14. Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline-2-carboxylate

    15. Romet (tn)

    16. Repirinast [mi]

    17. Repirinast [inn]

    18. Repirinast [jan]

    19. Repirinast [usan]

    20. Repirinast [mart.]

    21. Isopentyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline-2-carboxylate

    22. Repirinast [who-dd]

    23. Schembl29997

    24. Repirinast (jan/usan/inn)

    25. Chembl2105300

    26. Chebi:32092

    27. Dtxsid10223349

    28. Zinc538285

    29. Bcp16315

    30. Ex-a3508

    31. My5116

    32. Akos016014130

    33. Ac-5020

    34. 4h-pyrano(3,2-c)quinoline-2-carboxylic Acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, 3-methylbutyl Ester

    35. 4h-pyrano(3,2-c)quinoline-2-carboxylic Acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, Isopentyl Ester

    36. Db-055720

    37. Hy-109544

    38. Cs-0031286

    39. Ft-0630818

    40. D01890

    41. 080r510

    42. A837709

    43. Q7314016

    2.4 Create Date
    2005-03-25
    3 Chemical and Physical Properties
    Molecular Weight 355.4 g/mol
    Molecular Formula C20H21NO5
    XLogP33.4
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count5
    Exact Mass355.14197277 g/mol
    Monoisotopic Mass355.14197277 g/mol
    Topological Polar Surface Area81.7 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity690
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Immunosuppressive Agents

    Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)

    Histamine Antagonists

    Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)

    Post Enquiry
    POST ENQUIRY